Is It Time to Buy Eli Lilly & Co.'s Stock?
Eli Lilly & Co. is promising big things, but has optimism in the stock gotten ahead of reality? It's time to ask if now's the right time to invest.
Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?
The world's largest pharmaceutical company, Pfizer, looks lost amid its staggering patent cliff problem. Could this experimental breast cancer drug put Pfizer back on track for growth?
Can Dividend Stock GlaxoSmithKline plc Bounce Back?
British pharma GlaxoSmithKline is being accused of corruption in yet another country, the United Arab Emirates. Given all the problems facing the company these days, can Glaxo turn things around?